Physician profile
Michael D Landers
NPI 1033223730
$2,081.96
in general payments reported to CMS, 2019-2025
20 companies · $1,457 in 2025
The $1,457 reported for 2025 was more than what 92% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.74 · 2021: $196 · 2022: $232 · 2023: $104 · 2024: $81.91 · 2025: $1,457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,010 · Travel and Lodging: $633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,009.57 |
| Travel and Lodging | $632.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $1,003.82 | 2024-2025 | Iovera, Zilretta |
| Bioventus LLC | $257.10 | 2022-2025 | Xcell, Durolane, Exogen Ultrasound Bone Healing System |
| Si-Bone, INC. | $140.74 | 2021 | |
| Biotissue Holdings INC. | $130.18 | 2025 | |
| Zimmer Biomet Holdings, INC. | $78.58 | 2025 | Gel-One Cross-Linked Hyaluronate, Visco-3 Sodium Hyaluronate |
| Medtronic, INC. | $59.59 | 2025 | Inceptiv, Intellis Adaptivestim |
| Stryker Corporation | $55.25 | 2021 | |
| Pylant Medical | $51.59 | 2022-2023 | |
| Next Science LLC | $51.05 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $42.83 | 2023 | Seglentis |
| Depuy Synthes Sales INC. | $32.09 | 2022 | |
| Sonex Health, INC. | $27.68 | 2022 | |
| Smith+Nephew, INC. | $25.09 | 2022 | |
| Polynovo North America LLC | $24.33 | 2024 | Novosorb Btm |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $24.09 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $18.56 | 2024 | Nuzyra |
| Ethicon US, LLC | $18.00 | 2022 | |
| Abbvie INC. | $15.23 | 2025 | |
| Horizon Therapeutics Plc | $14.42 | 2023 | Krystexxa |
| Ferring Pharmaceuticals INC. | $11.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Landers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.